National Institute of Dental & Craniofacial Research; Notice of Closed Meeting, 51289 [E9-23997]

Download as PDF 51289 Federal Register / Vol. 74, No. 192 / Tuesday, October 6, 2009 / Notices Internet. Section 10.33(b) provides that FDA may, for good cause, extend this 30-day period. Reconsideration of a denial or withdrawal of approval of a PMA may be sought only by the applicant; in these cases, the 30-day period will begin when the applicant is notified by FDA in writing of its decision. The regulations provide that FDA publish a quarterly list of available safety and effectiveness summaries of PMA approvals and denials that were announced during that quarter. The following is a list of approved PMAs for which summaries of safety and effectiveness were placed on the Internet from January 1, 2009, through March 31, 2009. There were no denial actions during this period. The list provides the manufacturer’s name, the product’s generic name or the trade name, and the approval date. TABLE 1.—LIST OF SAFETY AND EFFECTIVENESS SUMMARIES FOR APPROVED PMAS MADE AVAILABLE FROM JANUARY 1, 2009, THROUGH MARCH 31, 2009 PMA No. Docket No. Applicant Trade Name Approval Date P060030 FDA–2009–M–0033 Roche Molecular Systems, Inc. Cobas ampliprep/cobas taqman HFC test October 30, 2008 P950009 (S8) FDA–2009–M–0016 BD Diagnostics BD focal point gs imaging system December 3, 2008 P080010 FDA–2009–M–0034 Advanced Medical Optics, Inc. Tecnis multifocal foldable posterior chamber intraocular lens January 16, 2009 P080021 FDA–2009–M–0049 Advanced Vision Science, Inc. xact foldable hydrophobic acrylic UV light absorbing posterior chamber IOL February 2, 2009 P030031 (S11) FDA–2009–M–0071 Biosense Webster, Inc. Navistar & Celsius thermo cool catheters February 6, 2009 P070014 FDA–2009–M–0127 Bard Peripheral Vascular, Inc. lifestent flexstar & flexstar XL vascular stent system February 13, 2009 P940015 (S12) FDA–2009–M–0128 Genzyme Corp. Synvisc-One February 26, 2009 P070005 FDA–2009–M–0135 Synthemed Corp. Repel-cv bioresorbable adhesion barrier March 6, 2009 P080002 FDA–2009–M–0159 The Female Health Co. FC2 female condom March 10, 2009 II. Electronic Access Persons with access to the Internet may obtain the documents at https:// www.fda.gov/cdrh/pmapage.html. Dated: September 24, 2009. Jeffrey Shuren, Acting Director, Center for Devices and Radiological Health. [FR Doc. E9–23962 Filed 10–5–09; 8:45 am] BILLING CODE 4160–01–S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jlentini on DSKJ8SOYB1PROD with NOTICES National Institute of Dental & Craniofacial Research; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., VerDate Nov<24>2008 16:15 Oct 05, 2009 Jkt 220001 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Dental and Craniofacial Research Special Emphasis Panel; Review of P01 applications on Interdisciplinary Research on Oral Manifestations of HIV/AIDS in Vulnerable Populations. Date: November 12, 2009. Time: 9 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Victor Henriquez, PhD, Scientific Review Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 20892–4878, 301–451–2405, henriquv@nidcr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral Diseases and Disorders Research, National Institutes of Health, HHS) PO 00000 Frm 00037 Fmt 4703 Sfmt 4703 Dated: September 29, 2009. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E9–23997 Filed 10–5–09; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2009–N–0664] Pediatric Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. Name of Committee: Pediatric Advisory Committee. E:\FR\FM\06OCN1.SGM 06OCN1

Agencies

[Federal Register Volume 74, Number 192 (Tuesday, October 6, 2009)]
[Notices]
[Page 51289]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-23997]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Dental & Craniofacial Research; Notice of 
Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Dental and Craniofacial 
Research Special Emphasis Panel; Review of P01 applications on 
Interdisciplinary Research on Oral Manifestations of HIV/AIDS in 
Vulnerable Populations.
    Date: November 12, 2009.
    Time: 9 a.m. to 3 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Victor Henriquez, PhD, Scientific Review 
Officer, DEA/SRB/NIDCR, 6701 Democracy Blvd., Room 668, Bethesda, MD 
20892-4878, 301-451-2405, henriquv@nidcr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.121, Oral 
Diseases and Disorders Research, National Institutes of Health, HHS)


    Dated: September 29, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. E9-23997 Filed 10-5-09; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.